About This Report
This new 280-pages report from Venture Planning Group presents detailed analysis of the Italian STD market, including sales forecasts and supplier shares for Chancroid, Chlamydia, Gonorrhea, Herpes (I/II, VI), Papillomavirus (Pap Smear, HPV), and Syphilis. The report provides test volume and sales projections for Hospitals and Commercial/Private Labs.
In addition to market share and sales forecasts, the report:
- Examines market applications of Molecular Diagnostics,
Monoclonal Antibodies, Immunoassays, IT and other emerging technologies;
- Reviews features and operating characteristics of major analyzers used
for STD testing;
- Profiles key suppliers and potential market entrants developing innovative
technologies and products; and
- Analyzes emerging opportunities, alternative market penetration strategies,
market entry barriers/risks, and strategic planning issues.
The report is based on a combination of primary and secondary information sources, including interviews with laboratory directors, and executives of leading diagnostics companies and start-up firms developing innovative products.
In addition to primary sources of information, a comprehensive review of
the most recent technical and business publications, manufacturer product
and financial literature, as well as Venture Planning Groups proprietary data files was conducted.
Contains 280 pages and 14 tables
SIMILAR MARKET STUDIES
2016 Spain Tumor Marker Testing Market: Supplier Shares by Test, Country Volume and Sales Segment Forecasts, Innovative Technologies, Instrumentation Review, Competitive Strategies, Emerging Opportunities (DataPack)
This DataPack contains tables from VPGMarketResearch.com new report, 2016 Spain Tumor Marker Testing Market: Supplier Shares by Test, Country Volume and Sales Segment Forecasts, Innovative Technologies, Instrumentation Review, Competitive Strategies, Emerging Opportunities. For pricing information on DataPack sections or individual tables, please contact Customer Service.
February 2016 | $0 | View Details >>
About Oncology Biosimilars Biosimilars are follow-on versions of biological medicines that are developed after the expiry of the patent protection on the original product. Biosimilar medicines have a mechanism of action that is similar to that of the original biological medicines. Though biosimilars have many similarities to the innovator product, they ...
November 2014 | $2500 | View Details >>
China's demand for Point of Care Testing (POCT) Devices has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial ...
May 2016 | $4000 | View Details >>
Complete report $19,700. DataPack (test volumes, sales forecasts, supplier shares) $12,800. Summary This comprehensive five-country report contains 450 pages, 160 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the European hematology and flow cytometry markets during the next ...
October 2013 | $12800 | View Details >>
UPCOMING MARKET RESEARCH REPORTS
2017 © Copyright Big Market Research